Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Boehringer Ingelheim
McKesson
AstraZeneca
Medtronic

Last Updated: December 7, 2021

DrugPatentWatch Database Preview

Details for Patent: 10,392,406


Email this page to a colleague

« Back to Dashboard

Which drugs does patent 10,392,406 protect, and when does it expire?

Patent 10,392,406 protects XOFLUZA and is included in two NDAs.

This patent has fifty-four patent family members in thirty-four countries.

Summary for Patent: 10,392,406
Title:Substituted polycyclic pyridone derivatives and prodrugs thereof
Abstract: The present invention provides the following compounds having anti-viral activity. ##STR00001## A.sup.1 is CR.sup.1AR.sup.1B, S or O; A.sup.2 is CR.sup.2AR.sup.2B, S or O; A.sup.3 is CR.sup.3AR.sup.3B, S or O; A.sup.4 is CR.sup.4AR.sup.4B, S or O; the number of hetero atoms among atoms constituting the ring which consists of A.sup.1, A.sup.2, A.sup.3, A.sup.4, nitrogen atom adjacent to A.sup.1 and carbon atom adjacent to A.sup.1, is 1 or 2; R.sup.1A and R.sup.1B are each independently hydrogen, halogen, alkyl, or the like; R.sup.2A and R.sup.2B are each independently hydrogen, halogen, alkyl, or the like; R.sup.3A and R.sup.3B are each independently hydrogen, halogen, alkyl, or the like; R.sup.4A and R.sup.4B are each independently hydrogen, halogen, alkyl, or the like; R.sup.3A and R.sup.3B may be taken together to form non-aromatic carbocycle or non-aromatic heterocycle; X is CH.sub.2, S or O; R.sup.1 is each independently halogen, hydroxy, or the like; m is any integer of 0 to 2; and n is any integer of 1 to 2.
Inventor(s): Kawai; Makoto (Osaka, JP)
Assignee: SHIONOGI & CO., LTD. (Osaka, JP)
Application Number:15/569,191
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 10,392,406

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Genentech Inc XOFLUZA baloxavir marboxil FOR SUSPENSION;ORAL 214410-001 Nov 23, 2020 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-001 Oct 24, 2018 RX Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-002 Oct 24, 2018 RX Yes Yes ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
Genentech Inc XOFLUZA baloxavir marboxil TABLET;ORAL 210854-003 Mar 18, 2021 RX Yes No ⤷  Try it Free ⤷  Try it Free Y ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,392,406

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2015-090909Apr 28, 2015
Japan2015-236844Dec 3, 2015
PCT Information
PCT FiledApril 27, 2016PCT Application Number:PCT/JP2016/063139
PCT Publication Date:March 11, 2016PCT Publication Number: WO2016/175224

International Family Members for US Patent 10,392,406

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 104428 ⤷  Try it Free
Australia 2016256125 ⤷  Try it Free
Brazil 112017022550 ⤷  Try it Free
Canada 2984130 ⤷  Try it Free
Chile 2017002711 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Medtronic
Harvard Business School
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.